COLA President’s Corner, Winter 2013

By COLA CEO Douglas Beigel The Healthcare System’s Perfect Storm You hear the term “perfect storm” a lot. It typically means that a unique alignment of circumstances has occurred, one which has the potential to produce major changes in an existing status quo. The nation’s healthcare system – and with it, the clinical laboratory community…

CLIA Regulations

COLA visits AdvaMed to discuss PCLE initiative

COLA CEO Doug Beigel, COO Paul Campognone, Chief Marketing Officer James Liggins, and Government and External Affairs Manager Richard Cross recently traveled to Washington to speak to about 30 members of AdvaMed, a trade association whose members make medical devices, diagnostic products and health information systems. The COLA representatives discussed the overall role of laboratory…

COLA Wins Prestigious Brandon Hall Award

COLA recently received a coveted Brandon Hall Group 2012 Excellence Awards Program. COLA received a Silver Award in the competition’s Learning Technology Implementations category. COLA was honored for the redesign of its labuniversity.org educational platform, designed to make it more convenient for physicians and laboratory staff to obtain laboratory training that meets certification and licensing…

PT Referral Bill Becomes Law

 On December 4, 2012, President Obama signed into law H. R. 6118 — the Taking Essential Steps for Testing (TEST) Act of 2012. The new law, which passed the U. S. House of Representatives in September and the Senate in November by voice vote, resolves a longstanding unresolved issue with respect to CLIA enforcement –…

Disaster Recovery: Six Things Labs Can Do

October, 2012 By Douglas Beigel, Chief Executive Officer COLA In October, during the week of lab-related events COLA hosted in Baltimore, we heard a number of inspirational stories related to lab medicine and the impact it has on patient safety. But during a week of great stories, one story stood out from among the rest.…

COLA Shares Important Information about the Meningitis Outbreak

The CDC has released the following diagnostic testing instructions for the Multistate Fungal Meningitis Outbreak Investigation. If you have any other questions please contact COLA directly at 1-800-981-9883. Diagnostic Testing for Septic Arthritis and Specimen Submission to CDC – Outbreak Associated with Injection of Potentially Contaminated Steroid Products The pathogens involved in this cluster of…

Credit: Architect of the Capitol

Legislation addressing PT Referral Controversy Moves in Congress

Legislation to resolve a longstanding issue with respect to CLIA enforcement – specifically, how federal regulators handle labs that mistakenly refer proficiency test samples(PT) to other labs – has moved forward in both houses of Congress. On September 20, H.R. 6118, the Taking Essential Steps for Testing Act (TEST Act), introduced by Rep. Michael Grimm…